All three SMO inhibitors are under investigation for treatment of solid tumors [194,195,196], and a known and approved antifungal drug itraconazole is being examined for potential clinical application for treatment of basal cell carcinoma [197]. The gene discussed is SMO; the disease is basal cell carcinoma.